Mai Capital Management Armata Pharmaceuticals, Inc. Transaction History
Mai Capital Management
- $13.2 Billion
- Q4 2024
A detailed history of Mai Capital Management transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Mai Capital Management holds 71 shares of ARMP stock, worth $149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71Holding current value
$149% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
25Shares Held
1.39MCall Options Held
0Put Options Held
10.3K-
Bank Of America Corp Charlotte, NC634KShares$1.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA234KShares$493,9910.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$225,3240.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$211,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX69.7KShares$147,0290.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $76.3M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...